INJECT, REPEAT
OBESITY & DIABETES CRISIS NEARLY 40% OF INDIAN ADULTS ARE OVERWEIGHT OR OBESE, WITH 11.4% LIVING WITH DIABETES, STRAINING HEALTHCARE
NEW DRUGS SEMAGLUTIDE AND TIRZEPATIDE, ORIGINALLY FOR DIABETES, AID IN WEIGHT LOSS, HELPING PATIENTS SHED UP TO 20% OF BODY WEIGHT
INDIA LAUNCH LIKELY BY 2025-26, PENDING TRIALS AND REGULATORY APPROVAL
MARKET GROWTH INDIA'S WEIGHT MANAGEMENT MARKET, WORTH ₹1.73 LAKH CRORE IN 2023, IS SET TO GROW AT 9.3% CAGR TO ₹3.99 LAKH CRORE BY 2032
LOCAL INNOVATION INDIAN COMPANIES LIKE SUN PHARMA, DR. REDDY'S, AND BIOCON ARE DEVELOPING AFFORDABLE ALTERNATIVES TO THESE COSTLY DRUGS
On Christmas Day, when Tesla CEO Elon Musk posed as a slim Santa Claus on X, he gave an unmatched public profile to the anti-obesity drugs Mounjaro and Ozempic with one comment. “Like Cocaine Bear, but Santa and Ozempic,” he said, adding, “Technically, Mounjaro, but that does not have the same ring to it.”
The sudden publicity (Musk has 209 million followers on X) was the icing on the cake. The companies that make these two drugs, Eli Lilly of the US (Mounjaro) and Novo Nordisk of Denmark (Ozempic) are already the darlings of shareholders, with Eli Lilly at No. 13 and Novo Nordisk at No. 25 on a market capitalisation listing. Musk’s Tesla was at No. 8.
So why are people going nuts over these drugs? Cut to a close shot of aam aadmi and obesity.
この記事は Business Today India の January 19, 2025 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Business Today India の January 19, 2025 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
"Do what's best for employees"
BEST ADVICE - PANKAJ JATHAR | CEO | NIIT LTD
Your Palate for 2025
What's in store for you in the New Year when you go out for a meal or a drink? We ask industry experts to predict F&B trends for 2025
"RBI'S STANCE SHOULD BE TO KEEP THE RUPEE MORE VOLATILE"
Axis Bank Chief Economist Neelkanth Mishra talks about the rupee, quantitative easing, the Trump impact, and more
"We should strive towards two non-zero GST rates"
Arvind Panagariya, Chairman of the 16th Finance Commission, on further reforms in the economy, the Nehruvian era and its impact on policymaking, cash transfers, and more
A GENERATION MAROONED
This generation is creating new grammar for social and professional existence. They are reimagining the very concept of work, identity, and social belonging
A TIME OF UNCERTAINTY AND OPPORTUNITY
A look at the key trends that will redefine how content will be created, distributed, and consumed
Consciousness Shaping Consumption
India has a dynamic and discerning consumer base, whose consumption pattern is experiencing a significant transformation
THE NIFTY ELEPHANTS
The composition of the Nifty 50 index has undergone notable changes in the past 30 years, with only 11 companies consistently remaining in the index. It is expected to undergo further changes in 2025 with the entry of new-age companies like Zomato
REDEFINING THE DIGITAL AGE
For Bitcoin, its future lies not as a currency but as a cornerstone of the modern financial ecosystem
THE FUTURE OF HEALTHCARE
As AI advances, so will its role in health insurance. In the future, it shall perform a variety of complex tasks, making it more accessible and aligned with individual needs
